Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Antigen binding" describes the process or property by which proteins, primarily antibodies, attach to specific antigens via a highly variable region (the antigen-binding site or paratope) at the tips of their Y-shaped structure. This is an essential feature of immune recognition, enabling antibodies to identify and neutralize foreign molecules such as viruses and bacteria. The antigen-binding site is formed by the variable domains of the heavy (VH) and light (VL) chains, especially the complementarity-determining regions (CDRs). "Antigen binding" is not itself a molecular target but refers to a binding property common to immunoglobulins and some related synthetic or engineered proteins[1][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antigen binding.